Tatsis Ourania
SEC insider (Form 3/4/5 filer). CIK 0001789815. EVP, Chief Reg. & Quality Off. at VERTEX PHARMACEUTICALS INC / MA (VRTX) and 2 other issuers. 33 reported Form 4/5 transactions since Sep 2024; latest on Jul 21, 2026. Located in BOSTON, MA.
Companies Tatsis Ourania has filed insider reports for
- VERTEX PHARMACEUTICALS INC / MA (VRTX): Officer, EVP, Chief Reg. & Quality Off.
- Odyssey Therapeutics, Inc. (ODTX): Director
- Verve Therapeutics, Inc. (VERV): Director
Tatsis Ourania
CIK: 0001789815
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Jul 21, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirect8.3K shares- - Jul 2, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect1.5K shares at avg. $524.99$787K - May 7, 2026ODTX
Odyssey Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
27.4K shares- - Feb 25, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect260 shares at avg. $486.35$126K - Feb 24, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
Tax PaymentDirect1.6K shares at avg. $485.11$789K - Feb 18, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect368 shares at avg. $473.68$174K - Feb 17, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
Tax PaymentDirect2.3K shares at avg. $483.75$1.1M - Feb 17, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirect5.8K shares- - Feb 17, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect609 shares at avg. $489.46$298K - Feb 13, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect1.5K shares at avg. $499.99$750K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 21, 2026 |  VRTX VERTEX PHARMACEUTICALS INC / MA | Award | 8,251 | - | $0 | Direct |
| Jul 2, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 1,500 | $524.99 | $787,485 | Direct |
| May 7, 2026 |  ODTX Odyssey Therapeutics, Inc. | Award Stock Option (Right to Buy) | 27,393 | - | - | Direct |
| Feb 25, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 260 | $486.35 | $126,451 | Direct |
| Feb 24, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tax Payment | 1,627 | $485.11 | $789,274 | Direct |
| Feb 18, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 368 | $473.68 | $174,314 | Direct |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tax Payment | 2,294 | $483.75 | $1,109,723 | Direct |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award | 5,789 | - | $0 | Direct |
| Feb 17, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 609 | $489.46 | $298,081 | Direct |
| Feb 13, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 1,500 | $499.99 | $749,985 | Direct |
1-10 of 33 transactions